Similarity in the functions of HIF‑1α and HIF‑2α proteins in cervical cancer cells

Jiang,Lixia; Shi,Shaohua; Shi,Qiaofa; Zhang,Huijuan; Hu,Rong; Wang,Meizhen

doi:10.3892/ol.2017.6837

Similarity in the functions of HIF‑1α and HIF‑2α proteins in cervical cancer cells

Authors:
- Lixia Jiang
- Shaohua Shi
- Qiaofa Shi
- Huijuan Zhang
- Rong Hu
- Meizhen Wang
View Affiliations

Affiliations: Department of Clinical Examination, The First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi 341000, P.R. China, Department of Immunology, Medical College of Nanchang University, Nanchang, Jiangxi 330006, P.R. China, Department of Medicine, Nanchang University Hospital, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: August 28, 2017 https://doi.org/10.3892/ol.2017.6837
Pages: 5643-5651

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hypoxia is a common feature of many solid tumours, including cervical cancer. Aggressive tumour progression is mostly associated with hypoxia. Furthermore, hypoxic conditions in tumours are also associated with resistance to chemotherapy and radiation, and with poor prognosis. Hypoxia inducible factor (HIF)‑1, composed of a constitutively expressed β‑subunit (HIF‑β/ARNT) and one of the three known oxygen‑regulated α‑subunits, HIF‑1α, HIF‑2α, or HIF‑3α, mediates the tumour cell response to hypoxia. The distinction between the roles of HIF‑1α and HIF‑2α in tumorigenesis is not clearly delineated. Therefore, the aim of the present study was to investigate the effect of HIF‑2α on the characteristics of a cervical cancer cell line and to compare the functions of HIF‑1α and HIF‑2α. The present study demonstrated that the levels of HIF‑1α and HIF‑2α expression increased under hypoxic exposure compared with normoxia. The major difference was the temporal expression of HIF‑1α and HIF‑2α, with expression of the two proteins peaking at different time-points. In addition, HIF‑1α and HIF‑2α had similar effects on proliferation, cell cycle and apoptosis. Suppression of expression of HIF‑1α or HIF‑2α inhibited proliferation, induced G1‑phase arrest and promoted apoptosis in the cervical cancer cell line CaSki. However, the effects of HIF‑1α and HIF‑2α on invasion and cell autophagy were different. The inhibitory effect of HIF‑1α on cell invasion was stronger compared with HIF‑2α, while the inhibitory effect of HIF‑1α on cell autophagy was weaker compared with HIF‑2α. Together, these results demonstrate that HIF‑1α and HIF‑2α have similar effects on the characteristics of a cervical cancer cell line. The major difference that the authors observed between the effects exerted by the two proteins on the cervical cancer cell line studied is the extent of their effect on invasion and autophagy.

View Figures

View References

1	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
2	Kawano M, Mabuchi S, Matsumoto Y, Sasano T, Takahashi R, Kuroda H, Kozasa K, Hashimoto K, Isobe A, Sawada K, et al: The significance of G-CSF expression and myeloid-derived suppressor cells in the chemoresistance of uterine cervical cancer. Sci Rep. 5:182172015. View Article : Google Scholar : PubMed/NCBI
3	Eifel PJ, Winter K, Morris M, Levenback C, Grigsby PW, Cooper J, Rotman M, Gershenson D and Mutch DG: Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: An update of radiation therapy oncology group trial (RTOG) 90–01. J Clin Oncol. 22:872–880. 2004. View Article : Google Scholar : PubMed/NCBI
4	Li SH, Shin DH, Chun YS, Lee MK, Kim MS and Park JW: A novel mode of action of YC-1 in HIF inhibition: Stimulation of FIH-dependent p300 dissociation from HIF-1{alpha}. Mol Cancer Ther. 7:3729–3738. 2008. View Article : Google Scholar : PubMed/NCBI
5	Lou JJ, Chua YL, Chew EH, Gao J, Bushell M and Hagen T: Inhibition of hypoxia-inducible factor-1alpha (HIF-1alpha) protein synthesis by DNA damage inducing agents. PLoS One. 5:00105222010. View Article : Google Scholar
6	Zhang J, Cao J, Weng Q, Wu R, Yan Y, Jing H, Zhu H, He Q and Yang B: Suppression of hypoxia-inducible factor 1α (HIF-1α) by tirapazamine is dependent on eIF2α phosphorylation rather than the mTORC1/4E-BP1 pathway. PLoS One. 5:00139102010. View Article : Google Scholar
7	Rankin EB and Giaccia AJ: The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ. 15:678–685. 2008. View Article : Google Scholar : PubMed/NCBI
8	Hu CJ, Sataur A, Wang L, Chen H and Simon MC: The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Mol Biol Cell. 18:4528–4542. 2007. View Article : Google Scholar : PubMed/NCBI
9	Tian H, McKnight SL and Russell DW: Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:72–82. 1997. View Article : Google Scholar : PubMed/NCBI
10	Shah T, Krishnamachary B, Wildes F, Mironchik Y, Kakkad SM, Jacob D, Artemov D and Bhujwalla ZM: HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets. Oncotarget. 6:28104–28119. 2015. View Article : Google Scholar : PubMed/NCBI
11	Huang M, Chen Q, Xiao J, Yao T, Bian L, Liu C and Lin Z: Overexpression of hypoxia-inducible factor-1α is a predictor of poor prognosis in cervical cancer: A clinicopathologic study and a meta-analysis. Int J Gynecol Cancer. 24:1054–1064. 2014. View Article : Google Scholar : PubMed/NCBI
12	Ellingsen C, Andersen LM, Galappathi K and Rofstad EK: Hypoxia biomarkers in squamous cell carcinoma of the uterine cervix. BMC Cancer. 15:8052015. View Article : Google Scholar : PubMed/NCBI
13	Kim NS, Kang YJ, Jo JO, Kim HY, Oh YR, Kim YO, Jung MH, Ock MS and Cha HJ: Elevated expression of thymosin β4, vascular endothelial growth factor (VEGF) and hypoxia inducible factor (HIF)-1α in early-stage cervical cancers. Pathol Oncol Res. 17:493–502. 2011. View Article : Google Scholar : PubMed/NCBI
14	Tang B, Qu Y, Zhao F, Mao M, Tang J, Li X, Ferriero D and Mu D: In vitro effects of hypoxia-inducible factor 1alpha on the biological characteristics of the SiHa uterine cervix cancer cell line. Int J Gynecol Cancer. 19:898–904. 2009. View Article : Google Scholar : PubMed/NCBI
15	Schwock J, Geddie WR and Hedley DW: Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry. Cytometry A. 68:59–70. 2005. View Article : Google Scholar : PubMed/NCBI
16	Kim MK, Kim TJ, Sung CO, Choi CH, Lee JW, Bae DS and Kim BG: Clinical significance of HIF-2α immunostaining area in radioresistant cervical cancer. J Gynecol Oncol. 22:44–48. 2011. View Article : Google Scholar : PubMed/NCBI
17	Kawanaka T, Kubo A, Ikushima H, Sano T, Takegawa Y and Nishitani H: Prognostic significance of HIF-2alpha expression on tumor infiltrating macrophages in patients with uterine cervical cancer undergoing radiotherapy. J Med Invest. 55:78–86. 2008. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Lin Q, Wang Y, Chen D, Sheng X, Liu J and Xiong H: Cisplatin regulates cell autophagy in endometrial cancer cells via the PI3K/AKT/mTOR signalling pathway. Oncol Lett. 13:3567–3571. 2017.PubMed/NCBI
20	Lin D and Wu J: Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target. World J Gastroenterol. 21:12171–12178. 2015. View Article : Google Scholar : PubMed/NCBI
21	Masoud GN and Li W: HIF-1alpha pathway: Role, regulation and intervention for cancer therapy. Acta Pharm Sin B. 5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
22	Imamura T, Kikuchi H, Herraiz MT, Park DY, Mizukami Y, Mino-Kenduson M, Lynch MP, Rueda BR, Benita Y, Xavier RJ and Chung DC: HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer. 124:763–771. 2009. View Article : Google Scholar : PubMed/NCBI
23	Menrad H, Werno C, Schmid T, Copanaki E, Deller T, Dehne N and Brüne B: Roles of hypoxia-inducible factor-1alpha (HIF-1alpha) versus HIF-2alpha in the survival of hepatocellular tumor spheroids. Hepatology. 51:2183–2192. 2010. View Article : Google Scholar : PubMed/NCBI